Search the Journal

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

OMERACT 8: International Consensus Conference on Outcome Measures in Rheumatology

ORGANIZING COMMITTEE
Maarten Boers, The Netherlands, Chair OMERACT 8
Peter Brooks, Australia
Vibeke Strand, USA
Lee Simon, USA
Peter Tugwell, Canada

SCIENTIFIC ADVISORY COMMITTEE
Marcos Bosi-Ferraz, Brazil
Ferdinand Breedveld, The Netherlands  
Maxime Dougados, France
Duncan Gordon, Canada
Marc Hochberg, USA
Kent Johnson, Australia
Joachim Kalden, Germany
Lars Klareskog, Sweden
Chak Lau, Hong Kong
Ted Pincus, USA
Alan Silman, UK
Kenneth Saag, USA
Josef Smolen, Austria
Fred Wolfe, USA

ACKNOWLEDGMENT

Financial support was provided by the following pharmaceutical companies and their subsidiaries: Abbott Laboratories, USA; Actelion, USA; Alderbio, USA; Astellas, USA; Amgen, USA; Astra Zeneca, UK; Bristol-Myers Squibb, USA; Centocor, USA; Combinatorx, USA; Eli Lilly, USA; Cypress/Forest Laboratories Inc., USA; Genzyme, USA; GlaxoSmithKline, UK; Hoffman LaRoche, USA; Pierre Fabre, France; Merck & Co., USA; Novartis Pharma AG, Switzerland; Organon, The Netherlands; Pfizer, USA; Savient Pharmaceuticals Inc., USA; Targeted Genetics, USA; Wyeth Pharmaceuticals, USA.

We thank the Dutch Rheumatism Foundation for sponsorship of patients to attend the OMERACT Conference.

The Organizing and Scientific Advisory Committees wish to thank the Module leaders, Workshop leaders, Special Interest Group leaders, guest speakers; special thanks to Liz Lacasse, Jil Beardmore, Lara Maxwell, Leanne Idzerda, and Q2Q Communications.



Return to June 2007 Table of Contents



© 2007. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.